
Fisher & Paykel Healthcare Corporation Limited
FSPKFOTCHealthcare● Active
$22.52
+$1.97(+9.59%)
Market Cap$13.2B
P/E Ratio—
52W High$25.69
52W Low$16.35
Fisher & Paykel Healthcare Corporation Limited (FSPKF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FSPKF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.36B | $1.28B | $1.76B | $1.59B | $1.64B |
| Cost of Revenue | $0.85B | $0.75B | $0.70B | $0.64B | $0.63B |
| Gross Profit | $1.52B | $0.53B | $1.06B | $0.95B | $1.01B |
| Gross Margin %(computed) | 64.16% | 41.41% | 60.28% | 59.54% | 61.70% |
| Operating Expenses | |||||
| R&D Expenses | $0.24B | $0.23B | $0.20B | $0.17B | $0.15B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.84B | $0.90B | $0.81B | $0.71B | $0.64B |
| Operating Income | $0.67B | ($0.37B) | $0.25B | $0.33B | $0.51B |
| Operating Margin %(computed) | 28.52% | -28.98% | 14.47% | 21.07% | 31.00% |
| Interest Income | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.02B | $0.01B | $0.00B |
| Income Before Tax | $0.64B | $0.50B | $0.24B | $0.33B | $0.50B |
| Income Tax Expense | $0.16B | $0.13B | $0.10B | $0.08B | $0.13B |
| Net Income | $0.47B | $0.38B | $0.13B | $0.25B | $0.38B |
| Net Margin %(computed) | 20.03% | 29.46% | 7.54% | 15.76% | 22.95% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.81 | $0.64 | $0.23 | $0.43 | $0.65 |
| Wtd Avg Shares | 0.59B | 0.59B | 0.59B | 0.58B | 0.58B |
| EBITDA | $0.83B | $0.65B | $0.37B | $0.43B | $0.61B |
| EBITDA Margin %(computed) | 35.30% | 51.11% | 20.94% | 27.30% | 36.84% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · NZD · B
Explore more Fisher & Paykel Healthcare Corporation Limited data
About Fisher & Paykel Healthcare Corporation Limited (FSPKF) Income Statement
Fisher & Paykel Healthcare Corporation Limited (FSPKF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, FSPKF reported revenue of $2.36B, gross profit of $1.52B (gross margin 64.16%), and net income of $0.47B — a net profit margin of 20.03%.
Frequently asked questions
FSPKF · 4 questionsFisher & Paykel Healthcare Corporation Limited (FSPKF) reported revenue of $2.36B for 2026, up 84.5% year-over-year.
FSPKF revenueFSPKF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09